AirSculpt Technologies Inc AIRS
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-10-29 |
| Shares Out. | 70,550,000 |
| Website | airsculpt.com/ β |
| Phone | 13026587581 |
| Employees | 363 |
| Revenue | $39.4M |
| Gross Profit | $23.8M |
| Net Income | -$2.4M |
| Free Cash Flow | $6.9M |
| Total Assets | $192.0M |
| Total Liabilities | $91.7M |
| Equity | $100.3M |
About AirSculpt Technologies Inc
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
AirSculpt Technologies Inc is a publicly traded company under the ticker symbol AIRS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
7 analysts (2026-07-01)

